CANNITO, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 5.850
AS - Asia 3.657
EU - Europa 3.579
OC - Oceania 149
SA - Sud America 110
AF - Africa 66
Continente sconosciuto - Info sul continente non disponibili 9
Totale 13.420
Nazione #
US - Stati Uniti d'America 5.655
CN - Cina 2.046
IT - Italia 942
DE - Germania 405
IE - Irlanda 402
SE - Svezia 382
SG - Singapore 346
GB - Regno Unito 285
FR - Francia 245
HK - Hong Kong 237
FI - Finlandia 233
KR - Corea 232
JP - Giappone 224
CA - Canada 169
AU - Australia 144
UA - Ucraina 132
IN - India 130
ES - Italia 111
TW - Taiwan 99
PL - Polonia 95
VN - Vietnam 88
ID - Indonesia 66
AT - Austria 62
BR - Brasile 59
NL - Olanda 58
IR - Iran 54
EG - Egitto 39
CL - Cile 35
PK - Pakistan 34
TR - Turchia 33
BE - Belgio 30
DK - Danimarca 29
GR - Grecia 26
RU - Federazione Russa 26
CH - Svizzera 25
RO - Romania 24
MX - Messico 22
BY - Bielorussia 16
AR - Argentina 12
IL - Israele 12
PT - Portogallo 12
MY - Malesia 10
RS - Serbia 10
CZ - Repubblica Ceca 9
EU - Europa 9
IQ - Iraq 9
SN - Senegal 9
ZA - Sudafrica 9
NO - Norvegia 6
TH - Thailandia 6
MO - Macao, regione amministrativa speciale della Cina 5
AE - Emirati Arabi Uniti 4
LB - Libano 4
NZ - Nuova Zelanda 4
SA - Arabia Saudita 4
GE - Georgia 3
HR - Croazia 3
HU - Ungheria 3
JO - Giordania 3
LT - Lituania 3
PH - Filippine 3
BN - Brunei Darussalam 2
CM - Camerun 2
GH - Ghana 2
HN - Honduras 2
LU - Lussemburgo 2
AL - Albania 1
AO - Angola 1
BG - Bulgaria 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EC - Ecuador 1
ET - Etiopia 1
LK - Sri Lanka 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
WS - Samoa 1
ZM - Zambia 1
Totale 13.420
Città #
Chandler 722
Beijing 609
Dublin 395
Fairfield 358
Ann Arbor 331
Singapore 269
Ashburn 262
Torino 261
Houston 251
Seattle 230
Shanghai 220
Woodbridge 190
Wilmington 164
Redwood City 163
Jacksonville 140
Nyköping 133
Villeurbanne 121
Guangzhou 120
Cambridge 118
Dearborn 108
Princeton 107
Medford 104
Pisa 96
Brisbane 92
Nanjing 91
Montréal 89
Taipei 82
Warsaw 80
Boston 76
Xian 70
Milan 65
Munich 61
Düsseldorf 55
Dong Ket 54
Central 53
Jakarta 52
Boardman 48
Hangzhou 48
Wuhan 47
Turin 46
Vienna 45
Fremont 43
Mcallen 43
Zhengzhou 42
Hefei 41
Jinan 41
Chengdu 39
Florence 39
Tokyo 38
Washington 36
New York 34
Santiago 33
Fuzhou 32
Santa Clara 32
Shenyang 32
Barcelona 29
Rome 28
San Diego 27
Changsha 25
Helsinki 24
Hong Kong 24
Ottawa 24
Brussels 22
Central District 22
London 21
Tianjin 21
Padova 20
Chongqing 19
Madrid 19
Pittsburgh 19
Changchun 18
Kunming 18
Los Angeles 17
New Delhi 17
Norwalk 17
Jena 16
Seoul 16
Andrésy 15
Mountain View 15
Nanchang 15
Sydney 15
Renton 14
San Mateo 14
Silver Spring 14
Falls Church 13
Toronto 13
Cairo 12
Delhi 12
Mexico 12
Paris 12
Phoenix 12
Amsterdam 11
Bengaluru 11
Harbin 11
Lappeenranta 11
Nanning 11
Philadelphia 11
Tucson 11
Osaka 10
Porto Alegre 10
Totale 7.899
Nome #
Liver fibrosis: a dynamic and potentially reversible process. 1.091
Hypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine rich glycoprotein. 653
The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma. 606
EXPRESSION OF COX-2 IN HUMAN BREAST CANCER CELLS AS A CRITICAL DETERMINANT OF EPITHELIAL-MESENCHYMAL TRANSITION AND INVASIVENESS 588
Cellular And Molecular Mechanisms In Liver Fibrogenesis. 560
Hypoxia, hypoxia inducible factors and fibrogenesis in chronic liver diseases 515
Hepatic myofibroblasts and fibrogenic progression of chronic liver diseases 429
Hyaluronated mesoporous silica nanoparticles for active targeting: influence of conjugation method and hyaluronic acid molecular weight on the nanovector properties 405
Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. 347
The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cells. 279
Effects of the rare elements lanthanum and cerium on the growth of colorectal and hepatic cancer cell lines 276
Angiogenesis and liver fibrogenesis 246
Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells 238
Therapeutic pro-fibrogenic signaling pathways in fibroblasts 188
Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis 187
CLA reduces breast cancer cell growth and invasion through ERα and PI3K/Akt pathways 185
Dissection of the biphasic nature of hypoxia-induced motogenic action in bone marrow-derived human mesenchymal stem cells. 184
Liver fibrogenesis: un update on established and emerging basic concepts 181
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 180
Hepatic myofibroblasts: a heterogenous population of multifunctional cells in liver fibrogenesis 173
Hypoxia-inducible factor 2alpha drives the progression of experimental non-alcoholic fatty liver disease by stimulating hepatocyte production of histidine rich glycoprotein 171
SerpinB3 Promotes Pro-fibrogenic Responses in Activated Hepatic Stellate Cells 171
Cholangiocarcinoma tumor microenvironment highlighting fibrosis and matrix components 138
VEGF ed Angiopoietina-1: fattori ipossia- e leptina-dipendenti capaci di indurre migrazione e chemiotasssi in cellule stellate epatiche umane 136
4-Idrossinonenale come stimolo pro-fibrogenico selettivo per le cellule stellate umane attivate 129
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity. 127
SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets. 127
In vivo reprogramming of hepatic myofibroblasts into hepatocytes attenuates liver fibrosis: back to the future? 124
Microparticles released as a consequence of lipid-induced toxicity promote NLRP3 inflammasome activation in HepG2 cells. 117
Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells 104
SERPIN-B3 can contribute to fibrogenic progression of chronic liver diseases towards cirrhosis and HCC development 97
Microparticles released by fat-laden cells activate in a paracrine way NLRP3 inflammasome in both HepG2 cells and macrophages. 96
Microparticles released by fat-laden cells activate in a paracrine way NLRP3 inflammasome in both HepG2 cells and macrophages. 90
Hypoxia – induced migration of human hepatic stellate cellsrequires an early and redox sensitive activation of c-Jun N-terminal kinase 89
Common signalling events regulate migration and chemotaxis of hepatic stellate cells and bone marrow – derived mesenchymal stem cells 88
Chemotaxis in Profibrogenic Human Hepatic Stellate Cells Requires Redox – Dependent Activation of c-Jun N-Terminal Kinase Isoforms 1 and 2 88
ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis. 88
Oncostatin M, overexpressed in hepatocellular carcinoma, up-regulates SERPIN-B3 expression in hepatic cancer cells 87
Bcl-2 overexpression in human activated hepatic stellate cells: a survival and pro-fibrogenic mechanism 86
Common signalling and redox sensitive events regulate migration and chemotaxis of bone marrow – derived mesenchymal stem cells and hepatic stellate cells. 85
Oncostatin M stimulates directional migration of human hepatic pro-fibrogenic cells. 85
PDGF-BB as mitogenic and chemotactic stimulus for bone marrow – derived human mesenchymal stem cells, putative precursors of profibrogenic myofibroblast – like cells 84
NASH-related liver carcinogenesis is critically affected by hypoxia-inducible factor 2 alpha 83
Hypoxia - induced migration of human hepatic stellate cells requires an early and redox sensitive activation of c-jun n-terminal kinase 82
Oncostatin M stimulates chemotaxis of human hepatic profibrogenic cells 82
Beta-catenin triggers nuclear factor kB - dependent up-regulation of hepatocyte inducible nitric oxide synthase 82
Fibroinflammatory liver injuries as preneoplastic condition in cholangiopathies 81
Hepatic myofibroblasts: origin and role in liver fibrogenesis 80
PDGF-BB is an effective mitogenic and chemotactic stimulus for bone marrow – derived human mesenchymal stem cells, putative precursors of profibrogenic myofibroblast – like cells 79
Hypoxia drives epithelial mesenchymal transition in neoplastic cells of the gastro-intestinal tract: a beta-catenin and snail–mediated event favouring migration and/or invasiveness 78
Serpinb3 is overexpressed in the liver in presence of iron overload 78
Bone Marrow – Derived Mesenchymal Stem Cells Engraft Chronically Injured Liver and Differentiate Into Pro-fibrogenic Myofibroblast-Like Cells: the Role of PDGF-BB 77
Engraftment of bone marrow – derived human mesenchymal stem cells in normal and injured liver of NOD/SCID mice 76
Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis 76
Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: Engraftment and hepatocyte differentiation versus profibrogenic potential 75
Hepatocyte-specific deletion of HIF2α prevents NASH-related liver carcinogenesis by decreasing cancer cell proliferation 75
Sopravvivenza all’induzione di apoptosi in cellule stellate epatiche umane attivate: un’attitudine pro-fibrogenica 73
Silencing of Bcl-2 expression in human hepatic stellate cells turns off their survival attitude 72
Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts. 71
Positive correlation of HIF2alpha and serpinB3 in human hepatocellular carcinoma: selective and prognostic implications 70
A Cla response of Human Breast cancer cells: mechanisms involved 70
Redox-sensitive GSK-3 inhibition and late VEGF release mediate hypoxia – dependent epithelial mesenchymal transition and increased invasiveness in human HepG2 cells 69
Cytokine – induced migration of human hepatic stellate cells requires activation of c-jun n-terminal kinase and intracellular generation of reactive oxygen species 69
Cytoskeletal rearrangement by the mitogen-activated protein kinaseERK5 interferes with the motile and invasive phenotype ofhepatocellular carcinoma cells 69
HIF2alpha neddylation as a selective serpinb3-dependent mechanism leading to its increased stabilization and nuclear translocation in liver cancer cells 68
Epithelial – mesenchymal transition in human hepatocellular carcinoma cells under hypoxia: a beta catenin and SNAIL – mediated event favouring migration and/or invasiveness 65
Survival and phenotypic responses of fully activated human hepatic stellate cells to superoxide and TNF: critical role of generation rate and Bcl-2 levels 65
Hepatocyte-derived microparticles promote NLRP3 inflammasome activation in HepG2 cells 65
Hypoxia and angiogenesis in the progression of chronic liver diseases towards cirrhosis and hepatocellular carcinoma. 64
Intracellular redox changes and c- jun n-terminal kinase as crucial events in cytokine – induced chemotaxis of human activated hepatic stellate cells 63
Cytoskeletal rearrangement by the mitogen-activated protein kinase ERK5 interferes with the motile and invasive phenotype of hepatocellular carcinoma cells. 63
Dose-dependent and divergent effects of superoxide anion on cell death, proliferation and migration of activated human hepatic stellate cells 62
Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans 61
SERPINB3 induces epithelial-mesenchymal transition. 59
Redox-dependent induction of epithelial to mesenchymal transition and increased invasiveness by oncostatin M in hepatic cancer cells. 59
Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells 59
Positive correlation of HIF2α and SERPINB3 in human hepatocellular carcinoma: selectivity and prognostic implications 58
Multiple molecular mechanisms sustain hypoxia - dependent epithelial - mesenchymal transition and increased invasiveness in human cancer cells 58
Redox-sensitive GSK-3 inhibition and late VEGF release mediate hypoxia – dependent epithelial mesenchymal transition in and increased invasiveness in human HepG2 cells 57
Epithelial-Mesenchymal Transition: From Molecular Mechanisms, Redox Regulation to Implications in Human Health and Disease 57
Silencing of Bcl-2 by specific siRNA sensitizes human-activated hepatic stellate cells to TNF – induced apoptosis 56
EXPRESSION OF COX-2 IN HUMAN BREAST CANCER CELLS AS A CRITICAL DETERMINANT OF EPITHELIAL-MESENCHYMAL TRANSITION AND INVASIVENESS 56
GPR21 inhibition increases glucose-uptake in HepG2 cells 54
Hepatic angiogenesis and fibrogenesis in the progression of chronic liver diseases 53
Hepatic myofibroblasts in liver fibrogenesis 52
Oncostatin M, a novel profibrogenic mediator, is involved in the progression non-alcoholic fatty liver disease and stimulates migration of myofibroblasts 51
VEGF and Angiopoietin-1 as chemotactic factors for activated human hepatic stellate cells 50
SERPIN-B3 INDUCES HIF2α NUCLEAR TRANSLOCATION IN HEPATIC CANCER CELLS: A PARACRINE LOOP ABLE TO AFFECT CANCER CELL BEHAVIOUR 49
VEGF and angiopoietin-1 as hypoxia-inducible, autocrine and paracrine chemotactic factors for human hepatic stellate cells 47
Hypoxia up-regulates SERPINB3 in hepatic cancer cells: a HIF-2α associated event related to invasiveness and epithelial to mesenchymal transition. 47
Iperespressione di Bcl-2 in cellule stellate epaticheumane: un meccanismo di sopravvivenza pro-fibrogenico in corso di epatopatie croniche 46
SERPINB3 AND YAP INTERPLAY INCREASES MYC ONCOGENIC ACTIVITY 46
Microparticles released as a consequence of lipid-induced toxicity promote NLRP3 inflammasome activation in HepG2 cells 46
Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells 44
Hypoxia up-regulates serpin B3 in HepG2 cells: a HIF-2α associated and redox sensitive event related to invasiveness and epithelial to mesenchymal transition 43
SERPIN-B3 INDUCES HIF2a NUCLEAR TRANSLOCATION IN HEPATIC CANCER CELLS: A PARACRINE LOOP ABLE TO AFFECT CANCER CELL BEHAVIOUR 41
ERK5 is overexpressed in experimental liver injury and in hepatocellular carcinoma (HCC), and is modulated by soluble factors in HCC cells. 39
ONCOSTATIN M IS OVEREXPRESSED IN HEPATOCELLULAR CARCINOMA AND CAN INDUCE EPITHELIAL TO MESENCHYMAL TRANSITION AND INCREASED INVASIVENESS IN HEPATIC CANCER CELLS BY TWO DISTINCT MECHANISMS 39
Serpin B3 and YAP interplay increase Myc oncogenic increase 39
Migration of human activated hepatic stellate cells induced by superoxide anion: a Ras/Erk – dependent event that does not affect proliferation 36
Totale 13.502
Categoria #
all - tutte 34.382
article - articoli 0
book - libri 0
conference - conferenze 12.725
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.107


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.612 0 0 0 236 102 220 234 170 214 219 122 95
2020/20211.629 154 145 130 104 139 117 136 84 154 151 116 199
2021/20221.733 172 111 53 160 114 72 99 87 120 108 337 300
2022/20232.140 220 197 60 252 168 468 165 157 202 47 121 83
2023/20241.805 153 189 105 81 272 207 163 172 23 132 129 179
2024/2025630 79 213 215 123 0 0 0 0 0 0 0 0
Totale 13.860